TOKYO -- Japan's Fujifilm Holdings said Monday that it has won an order to produce a key component of American biotechnology company Novavax's coronavirus vaccine candidate at a site in the U.K.
Biotechnology
Fujifilm to make Novavax coronavirus vaccine component in UK
Production will fulfill order from British government for 60m doses
U.S. President Donald Trump tours Fujifilm Diosynth Biotechnologies' Bioprocess Innovation Center in the state of North Carolina on July 27. © Reuters
Read Next
Latest on Biotechnology
